VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SGRY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SGRYSurgery Partners, Inc.
$16.56$2.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSGRYQuarterly Financials

Surgery Partners, Inc. (SGRY) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Surgery Partners, Inc. (SGRY) quarterly income statement — complete revenue, gross profit & net income history

SGRY Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue810.9M885M821.5M826.2M776M864.4M770.4M762.1M717.4M735.4M674.1M667.6M
Revenue Growth %4.5%2.38%6.63%8.41%8.17%17.54%14.29%14.16%7.69%4%8.62%8.48%
Cost of Goods Sold650.7M672.8M626.2M630.6M614.1M630.8M592.9M582.9M562.1M541.8M508.3M513.5M
COGS % of Revenue80.24%76.02%76.23%76.33%79.14%72.98%76.96%76.49%78.35%73.67%75.4%76.92%
Gross Profit160.2M212.2M195.3M195.6M161.9M233.6M177.5M179.2M155.3M193.6M165.8M154.1M
Gross Margin %19.76%23.98%23.77%23.67%20.86%27.02%23.04%23.51%21.65%26.33%24.6%23.08%
Gross Profit Growth %-1.05%-9.16%10.03%9.15%4.25%20.66%7.06%16.29%15.9%5.05%26.37%14.49%
Operating Expenses140.6M102M89.6M83.9M100M106.5M116.6M94.4M79.3M92.2M83.2M56.5M
OpEx % of Revenue17.34%11.53%10.91%10.15%12.89%12.32%15.14%12.39%11.05%12.54%12.34%8.46%
Selling, General & Admin140.6M126.8M323.8M36.1M36M36M29.2M40.3M33.2M20.9M36.8M31.2M
SG&A % of Revenue17.34%14.33%39.42%4.37%4.64%4.16%3.79%5.29%4.63%2.84%5.46%4.67%
Research & Development000000000000
R&D % of Revenue------------
Other Operating Expenses0-1000K-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income65.8M110.2M105.7M111.7M61.9M127.1M60.9M84.8M76M101.4M82.6M97.6M
Operating Margin %8.11%12.45%12.87%13.52%7.98%14.7%7.9%11.13%10.59%13.79%12.25%14.62%
Operating Income Growth %6.3%-13.3%73.56%31.72%-18.55%25.35%-26.27%-13.11%63.79%7.64%11.47%27.58%
EBITDA104.3M170.1M145.2M152M98.2M161M111.1M119.6M109.7M132.5M111.5M122M
EBITDA Margin %12.86%19.22%17.68%18.4%12.65%18.63%14.42%15.69%15.29%18.02%16.54%18.27%
EBITDA Growth %6.21%5.65%30.69%27.09%-10.48%21.51%-0.36%-1.97%36.95%7.03%7.31%16.75%
D&A (Non-Cash Add-back)38.5M59.9M39.5M40.3M36.3M33.9M50.2M34.8M33.7M31.1M28.9M24.4M
EBIT0235.2M365.9M111.7M61.9M127.1M60.9M84.8M76M101.4M82.6M97.6M
Net Interest Income0-192.6M-335.1M-67.9M-62.2M-52.9M-50M-51.5M-47.3M-48.7M-49.8M-47.7M
Interest Income000000000000
Interest Expense-69.1M192.6M335.1M67.9M62.2M52.9M50M51.5M47.3M48.7M49.8M47.7M
Other Income/Expense0-67.6M-74.9M-67.9M-62.2M-52.9M-50M-51.5M-47.3M-48.7M-49.8M-47.7M
Pretax Income-3.3M42.6M30.8M43.8M-300K74.2M10.9M33.3M28.7M52.7M32.8M49.9M
Pretax Margin %-0.41%4.81%3.75%5.3%-0.04%8.58%1.41%4.37%4%7.17%4.87%7.47%
Income Tax1.2M13.6M5.5M-1.1M0120.8M4.5M4.9M4.4M6M3.1M-7.8M
Effective Tax Rate %-36.36%31.92%17.86%-2.51%0%162.8%41.28%14.71%15.33%11.39%9.45%-15.63%
Net Income-35.9M-15M-22.7M-2.5M-37.7M-108.5M-31.7M-15.5M-12.4M-1M-4.9M18.9M
Net Margin %-4.43%-1.69%-2.76%-0.3%-4.86%-12.55%-4.11%-2.03%-1.73%-0.14%-0.73%2.83%
Net Income Growth %4.77%86.18%28.39%83.87%-204.03%-10750%-546.94%-182.01%50.2%95.73%80.4%202.72%
Net Income (Continuing)-35.9M29M25.3M44.9M-300K-46.6M6.4M28.4M24.3M46.7M29.7M57.7M
Discontinued Operations000000000000
Minority Interest1.79B1.81B1.82B1.83B1.85B1.85B1.65B1.67B1.39B1.37B1.31B1.29B
EPS (Diluted)-0.28-0.11-0.18-0.02-0.30-0.86-0.25-0.12-0.10-0.010.290.15
EPS Growth %6.67%87.21%28%83.58%-204.88%--186.21%-180%--103.48%203.57%-11.76%
EPS (Basic)-0.28-0.11-0.18-0.02-0.30-0.86-0.25-0.12-0.10-0.010.290.15
Diluted Shares Outstanding128.37M127.21M126.93M126.98M126.6M126.21M126.17M126.13M125.97M125.77M125.75M127.37M
Basic Shares Outstanding128.37M127.21M126.93M126.98M126.6M126.21M126.17M126.13M125.97M125.77M125.75M125.72M
Dividend Payout Ratio------------